Uracil reductase inactivators
US6268374A · kind A · utility
2Cited by
5References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1993 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | Jul 23, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a group of 5-substituted uracil derivatives which are inactivators of uracil reductase and which are particularly useful in cancer chemotherapy, especially in combination with antimetabolite antineoplastic agents such as 5-fluorouracil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.